Follow the people · Insider
John D. Quisel
John D. Quisel files insider transactions with the SEC as a chief executive officer of Disc Medicine (IRON). We hold 4 disclosed purchases and sales filed since 9 December 2013, 3 of them in the last 90 days.
- Files forIRON
- Disclosed buys and sells4 in all, 3 in the last 90 days
- Last disclosure18 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 29 December 2022 — 17 August 2026Chief Executive Officer · Disc Medicine (IRON)69 Form 4 lines · source: SEC Form 4
- Filed 28 November 2023 — 4 June 2026Director · Gossamer Bio (GOSS)4 Form 4 lines · source: SEC Form 4
- Filed 5 December 2013 — 2 January 2020EVP, Chief Business Officer · Acceleron Pharma (XLRN)175 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 33,000 shares of Disc MedicineSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 8,400 shares of Disc MedicineSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 12,712 shares of Disc MedicineSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 11,888 shares of Disc MedicineSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- exercised options over 33,000 shares of Disc Medicine (a derivative holding)SEC Form 418 August 2026Stock Option (Right to Buy) · traded 17 August 2026 · filed 18 August 2026
- exercised options over 25,584 shares of Disc MedicineSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- exercised options over 7,416 shares of Disc MedicineSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- ▼ sold on the open market 9,704 shares of Disc MedicineSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- ▼ sold on the open market 16,896 shares of Disc MedicineSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- ▼ sold on the open market 6,400 shares of Disc MedicineSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- exercised options over 25,584 shares of Disc Medicine (a derivative holding)SEC Form 414 July 2026Stock Option (Right to Buy) · traded 13 July 2026 · filed 14 July 2026
- exercised options over 7,416 shares of Disc Medicine (a derivative holding)SEC Form 414 July 2026Stock Option (Right to Buy) · traded 13 July 2026 · filed 14 July 2026
- exercised options over 34,000 shares of Disc MedicineSEC Form 423 June 2026Common Stock · traded 18 June 2026 · filed 23 June 2026
- ▼ sold on the open market 22,927 shares of Disc MedicineSEC Form 423 June 2026Common Stock · traded 18 June 2026 · filed 23 June 2026
- ▼ sold on the open market 9,522 shares of Disc MedicineSEC Form 423 June 2026Common Stock · traded 18 June 2026 · filed 23 June 2026
- ▼ sold on the open market 1,551 shares of Disc MedicineSEC Form 423 June 2026Common Stock · traded 18 June 2026 · filed 23 June 2026
- exercised options over 34,000 shares of Disc Medicine (a derivative holding)SEC Form 423 June 2026Stock Option (Right to Buy) · traded 18 June 2026 · filed 23 June 2026
- was granted 115,000 shares of Gossamer Bio (a derivative holding)SEC Form 45 June 2026Stock Option (Right to Buy) · traded 4 June 2026 · filed 5 June 2026
- ▼ sold on the open market 13,264 shares of Disc MedicineSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 13,264 shares of Disc MedicineSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- was granted 55,200 shares of Disc MedicineSEC Form 411 February 2026Common Stock · traded 10 February 2026 · filed 11 February 2026
- was granted 82,800 shares of Disc Medicine (a derivative holding)SEC Form 411 February 2026Stock Option (Right to Buy) · traded 10 February 2026 · filed 11 February 2026
- was granted 82,800 shares of Disc Medicine (a derivative holding)SEC Form 411 February 2026Stock Option (Right to Buy) · traded 10 February 2026 · filed 11 February 2026
- was granted 55,200 shares of Disc MedicineSEC Form 411 February 2026Common Stock · traded 10 February 2026 · filed 11 February 2026
- exercised options over 12,300 shares of Disc Medicine (a derivative holding)SEC Form 419 December 2025Stock Option (Right to Buy) · traded 19 December 2025 · filed 19 December 2025
- exercised options over 12,300 shares of Disc MedicineSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- exercised options over 40,000 shares of Disc Medicine (a derivative holding)SEC Form 415 December 2025Stock Option (Right to Buy) · traded 11 December 2025 · filed 15 December 2025
- exercised options over 40,000 shares of Disc MedicineSEC Form 415 December 2025Common Stock · traded 11 December 2025 · filed 15 December 2025
- ▼ sold on the open market 2,419 shares of Disc MedicineSEC Form 415 December 2025Common Stock · traded 11 December 2025 · filed 15 December 2025
- ▼ sold on the open market 4,337 shares of Disc MedicineSEC Form 415 December 2025Common Stock · traded 11 December 2025 · filed 15 December 2025
- ▼ sold on the open market 16,356 shares of Disc MedicineSEC Form 415 December 2025Common Stock · traded 11 December 2025 · filed 15 December 2025
- ▼ sold on the open market 16,888 shares of Disc MedicineSEC Form 415 December 2025Common Stock · traded 11 December 2025 · filed 15 December 2025
- exercised options over 10,000 shares of Disc Medicine (a derivative holding)SEC Form 411 September 2025Stock Option (Right to Buy) · traded 9 September 2025 · filed 11 September 2025
- exercised options over 10,000 shares of Disc MedicineSEC Form 411 September 2025Common Stock · traded 9 September 2025 · filed 11 September 2025
- exercised options over 34,800 shares of Disc Medicine (a derivative holding)SEC Form 411 July 2025Stock Option (Right to Buy) · traded 9 July 2025 · filed 11 July 2025
- exercised options over 34,800 shares of Disc MedicineSEC Form 411 July 2025Common Stock · traded 9 July 2025 · filed 11 July 2025
- ▼ sold on the open market 31,207 shares of Disc MedicineSEC Form 411 July 2025Common Stock · traded 9 July 2025 · filed 11 July 2025
- ▼ sold on the open market 3,593 shares of Disc MedicineSEC Form 411 July 2025Common Stock · traded 9 July 2025 · filed 11 July 2025
- exercised options over 5,200 shares of Disc Medicine (a derivative holding)SEC Form 48 July 2025Stock Option (Right to Buy) · traded 3 July 2025 · filed 8 July 2025
- exercised options over 5,200 shares of Disc MedicineSEC Form 48 July 2025Common Stock · traded 3 July 2025 · filed 8 July 2025
- ▼ sold on the open market 5,200 shares of Disc MedicineSEC Form 48 July 2025Common Stock · traded 3 July 2025 · filed 8 July 2025
- was granted 115,000 shares of Gossamer Bio (a derivative holding)SEC Form 426 June 2025Stock Option (Right to Buy) · traded 25 June 2025 · filed 26 June 2025
- exercised options over 7,000 shares of Disc Medicine (a derivative holding)SEC Form 48 April 2025Stock Option (Right to Buy) · traded 7 April 2025 · filed 8 April 2025
- exercised options over 7,000 shares of Disc MedicineSEC Form 48 April 2025Common Stock · traded 7 April 2025 · filed 8 April 2025
- ▼ sold on the open market 5,574 shares of Disc MedicineSEC Form 420 February 2025Common Stock · traded 18 February 2025 · filed 20 February 2025
- was granted 117,505 shares of Disc Medicine (a derivative holding)SEC Form 412 February 2025Stock Option (Right to Buy) · traded 10 February 2025 · filed 12 February 2025
- was granted 78,337 shares of Disc MedicineSEC Form 412 February 2025Common Stock · traded 10 February 2025 · filed 12 February 2025
- exercised options over 13,012 shares of Disc Medicine (a derivative holding)SEC Form 42 January 2025Stock Option (Right to Buy) · traded 30 December 2024 · filed 2 January 2025
- exercised options over 10,000 shares of Disc Medicine (a derivative holding)SEC Form 42 January 2025Stock Option (Right to Buy) · traded 31 December 2024 · filed 2 January 2025
- exercised options over 13,012 shares of Disc MedicineSEC Form 42 January 2025Common Stock · traded 30 December 2024 · filed 2 January 2025
- ▼ sold on the open market 11,112 shares of Disc MedicineSEC Form 42 January 2025Common Stock · traded 30 December 2024 · filed 2 January 2025
- ▼ sold on the open market 1,900 shares of Disc MedicineSEC Form 42 January 2025Common Stock · traded 30 December 2024 · filed 2 January 2025
- exercised options over 10,000 shares of Disc MedicineSEC Form 42 January 2025Common Stock · traded 31 December 2024 · filed 2 January 2025
- exercised options over 19,820 shares of Disc Medicine (a derivative holding)SEC Form 426 December 2024Stock Option (Right to Buy) · traded 23 December 2024 · filed 26 December 2024
- exercised options over 19,820 shares of Disc MedicineSEC Form 426 December 2024Common Stock · traded 23 December 2024 · filed 26 December 2024
- ▼ sold on the open market 3,414 shares of Disc MedicineSEC Form 426 December 2024Common Stock · traded 23 December 2024 · filed 26 December 2024
- ▼ sold on the open market 12,194 shares of Disc MedicineSEC Form 426 December 2024Common Stock · traded 23 December 2024 · filed 26 December 2024
- ▼ sold on the open market 4,212 shares of Disc MedicineSEC Form 426 December 2024Common Stock · traded 23 December 2024 · filed 26 December 2024
- exercised options over 12,791 shares of Disc Medicine (a derivative holding)SEC Form 418 December 2024Stock Option (Right to Buy) · traded 16 December 2024 · filed 18 December 2024
- exercised options over 12,791 shares of Disc MedicineSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- ▼ sold on the open market 219 shares of Disc MedicineSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- ▼ sold on the open market 5,767 shares of Disc MedicineSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- ▼ sold on the open market 6,305 shares of Disc MedicineSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- ▼ sold on the open market 500 shares of Disc MedicineSEC Form 418 December 2024Common Stock · traded 16 December 2024 · filed 18 December 2024
- exercised options over 3,000 shares of Disc Medicine (a derivative holding)SEC Form 410 July 2024Stock Option (Right to Buy) · traded 8 July 2024 · filed 10 July 2024
- exercised options over 3,000 shares of Disc MedicineSEC Form 410 July 2024Common Stock · traded 8 July 2024 · filed 10 July 2024
- was granted 115,000 shares of Gossamer Bio (a derivative holding)SEC Form 46 June 2024Non-qualified stock option (Right to Buy) · traded 6 June 2024 · filed 6 June 2024
- was granted 99,550 shares of Disc Medicine (a derivative holding)SEC Form 41 March 2024Stock Option (Right to Buy) · traded 10 January 2024 · filed 1 March 2024
- was granted 66,365 shares of Disc MedicineSEC Form 41 March 2024Common Stock · traded 10 January 2024 · filed 1 March 2024
- exercised options over 2,700 shares of Disc Medicine (a derivative holding)SEC Form 43 January 2024Stock Option (Right to Buy) · traded 29 December 2023 · filed 3 January 2024
- exercised options over 2,700 shares of Disc MedicineSEC Form 43 January 2024Common Stock · traded 29 December 2023 · filed 3 January 2024
- was granted 230,000 shares of Gossamer Bio (a derivative holding)SEC Form 429 November 2023Stock Option (Right to Buy) · traded 28 November 2023 · filed 29 November 2023
- was granted 132,002 shares of Disc Medicine (a derivative holding)SEC Form 43 January 2023Stock Option (Right to Buy) · traded 29 December 2022 · filed 3 January 2023
- ▼ sold on the open market 1,600 shares of Acceleron PharmaSEC Form 43 January 2020Common Stock · traded 2 January 2020 · filed 3 January 2020
- ▼ sold on the open market 4,242 shares of Acceleron PharmaSEC Form 43 January 2020Common Stock · traded 2 January 2020 · filed 3 January 2020
- ▼ sold on the open market 3,584 shares of Acceleron PharmaSEC Form 410 September 2019Common Stock · traded 10 September 2019 · filed 10 September 2019
- exercised options over 5,000 shares of Acceleron Pharma (a derivative holding)SEC Form 411 July 2019Option to Purchase Common Stock · traded 9 July 2019 · filed 11 July 2019
- exercised options over 2,346 shares of Acceleron Pharma (a derivative holding)SEC Form 411 July 2019Option to Purchase Common Stock · traded 9 July 2019 · filed 11 July 2019
- exercised options over 1,562 shares of Acceleron Pharma (a derivative holding)SEC Form 411 July 2019Option to Purchase Common Stock · traded 9 July 2019 · filed 11 July 2019
- exercised options over 5,000 shares of Acceleron PharmaSEC Form 411 July 2019Common Stock · traded 9 July 2019 · filed 11 July 2019
- exercised options over 2,346 shares of Acceleron PharmaSEC Form 411 July 2019Common Stock · traded 9 July 2019 · filed 11 July 2019
- exercised options over 1,562 shares of Acceleron PharmaSEC Form 411 July 2019Common Stock · traded 9 July 2019 · filed 11 July 2019
- ▼ sold on the open market 3,452 shares of Acceleron PharmaSEC Form 411 April 2019Common Stock · traded 9 April 2019 · filed 11 April 2019
- ▼ sold on the open market 100 shares of Acceleron PharmaSEC Form 411 April 2019Common Stock · traded 9 April 2019 · filed 11 April 2019
- ▼ sold on the open market 70 shares of Acceleron PharmaSEC Form 411 April 2019Common Stock · traded 9 April 2019 · filed 11 April 2019
- was granted 28,500 shares of Acceleron Pharma (a derivative holding)SEC Form 429 January 2019Option to Purchase Common Stock · traded 25 January 2019 · filed 29 January 2019
- was granted 4,800 shares of Acceleron PharmaSEC Form 429 January 2019Common Stock · traded 25 January 2019 · filed 29 January 2019
- ▼ sold on the open market 1,309 shares of Acceleron PharmaSEC Form 44 January 2019Common Stock · traded 2 January 2019 · filed 4 January 2019
- ▼ sold on the open market 300 shares of Acceleron PharmaSEC Form 44 January 2019Common Stock · traded 2 January 2019 · filed 4 January 2019
- ▼ sold on the open market 1,300 shares of Acceleron PharmaSEC Form 44 January 2019Common Stock · traded 2 January 2019 · filed 4 January 2019
- ▼ sold on the open market 2,558 shares of Acceleron PharmaSEC Form 44 January 2019Common Stock · traded 2 January 2019 · filed 4 January 2019
- ▼ sold on the open market 475 shares of Acceleron PharmaSEC Form 44 January 2019Common Stock · traded 2 January 2019 · filed 4 January 2019
- was granted 2,000 shares of Acceleron PharmaSEC Form 411 May 2018Common Stock · traded 10 May 2018 · filed 11 May 2018
- was granted 10,000 shares of Acceleron Pharma (a derivative holding)SEC Form 411 May 2018Option to Purchase Common Stock · traded 10 May 2018 · filed 11 May 2018
- ▼ sold on the open market 1,104 shares of Acceleron PharmaSEC Form 44 April 2018Common Stock · traded 3 April 2018 · filed 4 April 2018
- ▼ sold on the open market 100 shares of Acceleron PharmaSEC Form 44 April 2018Common Stock · traded 3 April 2018 · filed 4 April 2018
- was granted 28,950 shares of Acceleron Pharma (a derivative holding)SEC Form 45 March 2018Option to Purchase Common Stock · traded 1 March 2018 · filed 5 March 2018
- was granted 4,825 shares of Acceleron PharmaSEC Form 45 March 2018Common Stock · traded 1 March 2018 · filed 5 March 2018
- ▼ sold on the open market 4,333 shares of Acceleron PharmaSEC Form 44 January 2018Common Stock · traded 2 January 2018 · filed 4 January 2018
- ▼ sold on the open market 4,505 shares of Acceleron PharmaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 600 shares of Acceleron PharmaSEC Form 414 September 2017Common Stock · traded 12 September 2017 · filed 14 September 2017
- ▼ sold on the open market 8 shares of Acceleron PharmaSEC Form 414 September 2017Common Stock · traded 13 September 2017 · filed 14 September 2017
- was granted 7,900 shares of Acceleron PharmaSEC Form 414 March 2017Common Stock · traded 2 March 2017 · filed 14 March 2017
- was granted 46,300 shares of Acceleron Pharma (a derivative holding)SEC Form 414 March 2017Option to Purchase Common Stock · traded 2 March 2017 · filed 14 March 2017
- ▼ sold on the open market 300 shares of Acceleron PharmaSEC Form 46 January 2017Common Stock · traded 4 January 2017 · filed 6 January 2017
- ▼ sold on the open market 1,400 shares of Acceleron PharmaSEC Form 46 January 2017Common Stock · traded 4 January 2017 · filed 6 January 2017
- exercised options over 781 shares of Acceleron PharmaSEC Form 423 September 2016Common Stock · traded 21 September 2016 · filed 23 September 2016
- exercised options over 13,671 shares of Acceleron PharmaSEC Form 423 September 2016Common Stock · traded 21 September 2016 · filed 23 September 2016
- exercised options over 11,500 shares of Acceleron PharmaSEC Form 423 September 2016Common Stock · traded 21 September 2016 · filed 23 September 2016
- ▼ sold on the open market 45,952 shares of Acceleron PharmaSEC Form 423 September 2016Common Stock · traded 21 September 2016 · filed 23 September 2016
- exercised options over 781 shares of Acceleron Pharma (a derivative holding)SEC Form 423 September 2016Option to Purchase Common Stock · traded 21 September 2016 · filed 23 September 2016
- exercised options over 13,671 shares of Acceleron Pharma (a derivative holding)SEC Form 423 September 2016Option to Purchase Common Stock · traded 21 September 2016 · filed 23 September 2016
- exercised options over 11,500 shares of Acceleron Pharma (a derivative holding)SEC Form 423 September 2016Option to Purchase Common Stock · traded 21 September 2016 · filed 23 September 2016
- exercised options over 5,500 shares of Acceleron PharmaSEC Form 413 September 2016Common Stock · traded 12 September 2016 · filed 13 September 2016
- exercised options over 6,250 shares of Acceleron PharmaSEC Form 413 September 2016Common Stock · traded 12 September 2016 · filed 13 September 2016
- exercised options over 4,688 shares of Acceleron PharmaSEC Form 413 September 2016Common Stock · traded 12 September 2016 · filed 13 September 2016
- ▼ sold on the open market 21,438 shares of Acceleron PharmaSEC Form 413 September 2016Common Stock · traded 12 September 2016 · filed 13 September 2016
- exercised options over 5,500 shares of Acceleron Pharma (a derivative holding)SEC Form 413 September 2016Option to Purchase Common Stock · traded 12 September 2016 · filed 13 September 2016
- exercised options over 6,250 shares of Acceleron Pharma (a derivative holding)SEC Form 413 September 2016Option to Purchase Common Stock · traded 12 September 2016 · filed 13 September 2016
- exercised options over 4,688 shares of Acceleron Pharma (a derivative holding)SEC Form 413 September 2016Option to Purchase Common Stock · traded 12 September 2016 · filed 13 September 2016
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.